Momenta Pharmaceuticals Inc.

Plus: Readouts for Savara, Lyell and Novo Nordisk

At least 13 immunology-focused biotechs have been acquired for ≥$1B since start of 2020, with three of the deals announced this year

Plus: Goswami becomes CFO at Illumina, and updates from SOBI, BDGene, Nordic and more

Plus Huang becomes Zai CSO and updates from Aadi, VectorY, Fulcrum and Xenon

Data science deals, expanded pipeline diversity define Mathai Mammen’s five years as pharmaceuticals R&D leader at J&J

Plus new CSO at GlycoEra, and updates from Geron, Ysios, CBC and more

Plus Drew Young to head commercial at Anthos, NRx general counsel leaving

Plus Kaundinya named president and CEO at GlycoERA, and updates from Plexium, Alentis, ADCendo, Xcell and more

Precision BioSciences Inc. (NASDAQ:DTIL) named Alex Kelly CFO. Kelly joined the gene editing company as chief corporate affairs officer in October 2020 and has served as interim CFO since

Samantha Truex joined Atlas Venture as its first female venture partner. Truex’s history with the VC includes roles in its portfolio companies, most recently as CEO at Quench Bio. She was